Vivus attracts strong takeover interest

Vivus is understood to have attracted takeover attention from larger rivals including AstraZeneca, GlaxoSmithKline (GSK), Pfizer, Merck and perhaps also Shire. AstraZeneca and Johnson & Johnson are confidently understood to be examining…